IDXG — Interpace Biosciences Share News
0.000.00%
Last trade - 00:00- $45.71m
- $43.06m
- $38.73m
Brief: Interpace Diagnostics Changes Name To Interpace Biosciences, Announces Q3 Results
Cancer Genetics rises on reverse stock split, M&A advisory deal
Brief: Interpace Diagnostics Group Says Is Eligible For An Additional 180-Day Period To Regain Compliance
Brief: Interpace Announces New Contracts With Multiple Blue Cross Blue Shield Plans
Brief: Interpace Diagnostics May Sell Shares With Aggregate Offer Price Of Upto $4.8 Mln
Brief: Interpace Enters Strategic Partnership Agreement With Genecast Biotechnology To Partner With Biopharma Solutions In China
Brief: Interpace Diagnostics Reports Qtrly Loss Per Share $0.14
Brief: Interpace Diagnostics Says Board Established October 10 As Date Of Co's 2019 Annual Meeting Of Stockholders
Interpace Diagnostics: Up on Blue Cross Blue Shield contract
Brief: Interpace Announces Contract With Blue Shield Of California For Thygenext & Thyramir
Brief: Interpace Announces New Agreement With SelectHealth
Brief: Cancer Genetics Says Director Resigned From Board
U.S. STOCKS ON THE MOVE-Phillip Morris, Netflix, Ebay
U.S. STOCKS ON THE MOVE-Netflix, Ebay, Camber Energy, IBM
U.S. STOCKS ON THE MOVE-Netflix, IBM, eBay, Alcoa, United Rentals
Interpace Diagnostics: Up on deal to develop thyroid-related diagnostic products
Brief: Interpace Diagnostics Enters Agreement With Predictive Oncology To Enhance Diagnosis Of Thyroid Cancer Via AI-Driven Analysis
Cancer Genetics bounces on sale of biopharma business
Brief: Interpace Diagnostics Acquires Cancer Genetics' Biopharma Services Business